Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionSalvage TherapyDisease-Free SurvivalStem CellsCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinCytarabineRecurrenceMyeloablative AgonistsSurvival RateCarmustineHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaSurvival AnalysisBone Marrow PurgingDoxorubicinVincristineHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationPrognosisAmyloidosisRetrospective StudiesAntineoplastic AgentsHematopoietic Stem CellsBusulfanDexamethasoneBoronic AcidsChemotherapy, AdjuvantFollow-Up StudiesPyrazinesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedGraft SurvivalIfosfamideLymphoma, FollicularInduction ChemotherapyAntigens, CD34Lymphoma, T-Cell, PeripheralAutograftsTime FactorsLiver TransplantationThalidomideGranulocyte Colony-Stimulating FactorLymphomaLeukapheresisMesenchymal Stem Cell TransplantationCisplatinPodophyllotoxinPrednisoneNeoplasm, ResidualMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseTransplantation ChimeraLeukemia, Myeloid, AcuteTissue DonorsCord Blood Stem Cell TransplantationCarboplatinMitoxantroneDrug Administration ScheduleCell TransplantationLymphoma, B-CellProspective StudiesIdarubicinMyelodysplastic SyndromesNeoplasm Recurrence, LocalKidney TransplantationNeoplasms, Second PrimaryEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsLeukemia, Plasma CellInfusions, SpinalNeoplasm StagingBlood Component RemovalAntibodies, MonoclonalAdult Stem CellsBreast NeoplasmsFeasibility StudiesImmunosuppressive AgentsNeutropeniaNeoplasmsHistocompatibility TestingLeukemia, MyeloidFatal OutcomeCell Differentiation